Maternal Disorders in North America
How Maternal Disorders affects 3 countries in North America.
| # | Country | Share (%) |
|---|
Across the 3 countries in North America tracked in this dataset, maternal disorders accounts for an average of 0.0% of total deaths. The regional average of 0.0% falls below the global average of 0.5%, suggesting that North America has a comparatively lower burden of maternal disorders mortality than the world overall. In North America, maternal disorders mortality is comparatively low, benefiting from advanced medical infrastructure, robust screening programmes, and pharmaceutical innovation, though access remains uneven.
North America has among the world's highest health expenditure per capita, yet faces distinctive mortality challenges including the opioid epidemic, firearm violence, rising metabolic disease, and significant health disparities linked to race and income. Within North America, significant variation exists. United States records the highest share at 0.0% of total deaths, while Canada has the lowest at 0.01%. This 0.0 percentage-point spread reflects differences in exposure, health system capacity, demographic structure, and risk factor prevalence across the region. Country-level pages provide detailed mortality breakdowns, time trends, and comparisons for each nation.
Skilled birth attendance and access to emergency obstetric care (EmOC) — including caesarean section, blood transfusion, and treatment of pre-eclampsia with magnesium sulfate — are the most critical interventions. Antenatal care enables early detection and management of risk factors. Misoprostol for postpartum haemorrhage prevention can be administered by community health workers. Access to safe abortion services and contraception prevents deaths from unsafe abortion and unintended pregnancies. Iron and folic acid supplementation addresses anaemia. The WHO Quality of Care framework provides standards for maternal and newborn services.
The mortality estimates presented on this page are derived from the Global Burden of Disease (GBD) study, produced by the Institute for Health Metrics and Evaluation (IHME). The GBD synthesizes data from vital registration systems, verbal autopsies, cancer registries, and surveillance networks across more than 200 countries and territories. Death rates are expressed per 100,000 population and are age-standardized, which adjusts for differences in age structure between populations so that comparisons across countries and over time reflect genuine differences in mortality risk rather than demographic composition.
The dataset typically covers the period from 1990 to 2023, although availability varies by country and cause. When interpreting the figures for maternal disorders in North America, note that higher age-standardized rates indicate a greater mortality burden independent of whether a country's population is older or younger. Trends over time reveal whether public health interventions, economic development, and health system improvements have reduced or increased the toll of this condition in the region.
The cause-of-death categories used on this page follow the Global Burden of Disease cause hierarchy, a standardized classification that groups individual ICD-coded causes into clinically meaningful categories. The "share of deaths" metric shows what percentage of all deaths in a given country or region are attributed to maternal disorders. A rising share does not necessarily mean more people are dying from this cause — it may reflect success in reducing competing causes of death. Always examine both absolute rates and shares for a complete picture of mortality patterns in North America.